Human papillomavirus self-sampling with mRNA testing benefits routine screening.
Saved in:
| Title: | Human papillomavirus self-sampling with mRNA testing benefits routine screening. |
|---|---|
| Authors: | Auvinen E; Department of Virology, Helsinki University Hospital Diagnostic Center and University of Helsinki and HUS, Helsinki, Finland., Nieminen P; Department of Obstetrics and Gynecology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland., Pellinen J; City of Helsinki, Finland., Dillner J; Center for Cervical Cancer Prevention, Department of Pathology, Karolinska University Laboratory and Karolinska Institutet, Stockholm, Sweden., Tarkkanen J; Department of Pathology, Helsinki University Hospital Diagnostic Center and University of Helsinki, Helsinki, Finland., Virtanen A; Department of Pathology, Helsinki University Hospital Diagnostic Center and University of Helsinki, Helsinki, Finland. |
| Source: | International journal of cancer [Int J Cancer] 2022 Dec 01; Vol. 151 (11), pp. 1989-1996. Date of Electronic Publication: 2022 Jun 28. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
